Missed this insightful session on Dapzin (Dapagliflozin)? Don't miss out!

You can still catch up! Watch this pre-recorded session exploring Dapagliflozin (an SGLT2 inhibitor), its mechanism of action, clinical benefits, and role in managing Type 2 Diabetes, heart failure, and chronic kidney disease. Gain valuable insights into its cardiorenal protective effects, clinical evidence, and practical treatment considerations. Watch now and stay informed as we advance knowledge and promote quality patient care!